6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams came together and formed a healthcare focused investment firm with an in-depth focus and extensive coverage across China and the United States.
Seed Stage, Early Stage
0 to $50M
Healthcare, Medical Devices, Technology
China, US, Hong Kong
Normal VC financing process. It starts with a pitch by startups to the VC firm. If the VC firm is interested, they will reply and give the startup a question list for commercial due diligence (CDD) purpose. If CDD turns out to be good, financial due diligence (FDD) and legal due diligence (LDD) might take place. After that, the VC firm might send a term sheet to the startups and negotiation process starts from there. When both parties reach a consensus on terms and structure of the deal, share subscription agreement (SSA) and shareholders’ agreement (SHA) would be drafted and finalized. Deal closing includes payment and documentation and report to the appropriate authority.
As a vertical fund manager focused on healthcare, 6 Dimensions Capital has an unparalleled expertise in the field. 6 of 8 most senior leaders of the firm hold doctorate degrees in relevant majors. 2 of those 8 are females. 6 Dimensions Capital can invest at any stage, which means if a startup is backed by them from seed round, it can enjoy follow-on investments from 6 Dimensions in many rounds afterwards.